Overexpression of mitofusin 2 improves translocation of glucose transporter 4 in skeletal muscle of high‑fat diet‑fed rats through AMP‑activated protein kinase signaling

Kong,Dexian; Song,Guangyao; Wang,Chao; Ma,Huijuan; Ren,Luping; Nie,Qian; Zhang,Xuemei; Gan,Kexin

doi:10.3892/mmr.2013.1457

Overexpression of mitofusin 2 improves translocation of glucose transporter 4 in skeletal muscle of high‑fat diet‑fed rats through AMP‑activated protein kinase signaling

Authors:
- Dexian Kong
- Guangyao Song
- Chao Wang
- Huijuan Ma
- Luping Ren
- Qian Nie
- Xuemei Zhang
- Kexin Gan
View Affiliations

Affiliations: Department of Internal Medicine, Hebei Medical University, Shijiazhuang, Hebei 050017, P.R. China, Department of Endocrinology, Hebei General Hospital, Shijiazhuang, Hebei 050017, P.R. China
Published online on: May 2, 2013 https://doi.org/10.3892/mmr.2013.1457
Pages: 205-210

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Mitofusin 2 (Mfn2) is a mitochondrial membrane protein that plays a role in mitochondrial fusion and metabolism in mammalian cells. Previous studies have reported a positive correlation between Mfn2 expression and insulin sensitivity in non‑diabetic and type 2 diabetic subjects. Thus, the aim of the present study was to investigate whether Mfn2 overexpression improves insulin sensitivity of high‑fat diet (HFD) rats and the possible underlying mechanisms. Male SD rats were randomly divided into four groups: negative control; HFD; HFD plus adenoviral vectors; and HFD plus adenoviral vectors encoding Mfn2. Following an 11‑week treatment protocol, the euglycemic‑hyperinsulinemic clamp technique was applied to evaluate insulin sensitivity in rats. The skeletal muscles from rats in each group were analyzed by real‑time PCR and western blot analysis to determine glucose transporter 4 (GLUT4) expression, translocation and relative translocation signaling. Consistent with Mfn2 repression and glucose intolerance, HFD downregulates GLUT4 expression at the mRNA and protein levels, while Mfn2 overexpression activates AMP‑activated protein kinase (AMPK), increases GLUT4 expression and translocation and improves insulin resistance in the skeletal muscles of HFD rats. Results of the present study indicate that Mfn2 overexpression improves insulin sensitivity and may regulate GLUT4 translocation in an AMPK‑dependent manner in the skeletal muscles of HFD rats. This study is likely to provide insight into the unique role of Mfn2 in promoting glucose uptake, leading to modulation of GLUT4 translocation signaling and maintenance of glucose homeostasis in vivo.

View Figures

View References

1	Bach D, Naon D, Pich S, et al: Expression of Mfn2, the Charcot-Marie-Tooth neuropathy type 2A gene, in human skeletal muscle: effects of type 2 diabetes, obesity, weight loss and the regulatory role of tumor necrosis factor alpha and interleukin-6. Diabetes. 54:2685–2693. 2005. View Article : Google Scholar
2	van den Ouweland JM, Lemkes HH, Ruitenbeek W, et al: Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness. Nat Genet. 1:368–371. 1992.PubMed/NCBI
3	Zorzano A, Liesa M and Palacin M: Mitochondrial dynamics as a bridge between mitochondrial dysfunction and insulin resistance. Arch Physiol Biochem. 115:1–12. 2009. View Article : Google Scholar : PubMed/NCBI
4	Hoeks J and Schrauwen P: Muscle mitochondria and insulin resistance: a human perspective. Trends Endocrinol Metab. 23:444–450. 2012. View Article : Google Scholar : PubMed/NCBI
5	Bach D, Pich S, Soriano FX, et al: Mitofusin-2 determines mitochondrial network architecture and mitochondrial metabolism. A novel regulatory mechanism altered in obesity. J Biol Chem. 278:17190–17197. 2003. View Article : Google Scholar : PubMed/NCBI
6	Chen H, Detmer SA, Ewald AJ, Griffin EE, Fraser SE and Chan DC: Mitofusins Mfn1 and Mfn2 coordinately regulate mitochondrial fusion and are essential for embryonic development. J Cell Biol. 160:189–200. 2003. View Article : Google Scholar : PubMed/NCBI
7	Soriano FX, Liesa M, Bach D, Chan DC, Palacin M and Zorzano A: Evidence for a mitochondrial regulatory pathway defined by peroxisome proliferator-activated receptor-gamma coactivator-1 alpha, estrogen-related receptor-alpha and mitofusin 2. Diabetes. 55:1783–1791. 2006. View Article : Google Scholar
8	Sebastián D, Hernández-Alvarez MI, Segalés J, et al: Mitofusin 2 (Mfn2) links mitochondrial and endoplasmic reticulum function with insulin signaling and is essential for normal glucose homeostasis. Proc Natl Acad Sci USA. 109:5523–5528. 2012.PubMed/NCBI
9	Pich S, Bach D, Briones P, et al: The Charcot-Marie-Tooth type 2A gene product, Mfn2, up-regulates fuel oxidation through expression of OXPHOS system. Hum Mol Genet. 14:1405–1415. 2005. View Article : Google Scholar : PubMed/NCBI
10	McConell GK and Wadley GD: Potential role of nitric oxide in contraction-stimulated glucose uptake and mitochondrial biogenesis in skeletal muscle. Clin Exp Pharmacol Physiol. 35:1488–1492. 2008.PubMed/NCBI
11	Zhao HL, Liu LZ, Sui Y, et al: Fatty acids inhibit insulin-mediated glucose transport associated with actin remodeling in rat L6 muscle cells. Acta Diabetol. 47:331–339. 2010. View Article : Google Scholar : PubMed/NCBI
12	Jaiswal N, Yadav PP, Maurya R, Srivastava AK and Tamrakar AK: Karanjin from Pongamia pinnata induces GLUT4 translocation in skeletal muscle cells in a phosphatidylinositol-3-kinase-independent manner. Eur J Pharmacol. 670:22–28. 2011.
13	Kim JY, Jo KJ, Kim BJ, Baik HW and Lee SK: 17β-estradiol induces an interaction between adenosine monophosphate-activated protein kinase and the insulin signaling pathway in 3T3-L1 adipocytes. Int J Mol Med. 30:979–985. 2012.
14	Bi Y, Sun WP, Chen X, Li M, Liang H, Cai MY, Zhu YH, He XY, Xu F and Weng JP: Effect of early insulin therapy on nuclear factor kappaB and cytokine gene expressions in the liver and skeletal muscle of high-fat diet, streptozotocin-treated diabetic rats. Acta Diabetol. 45:167–178. 2008. View Article : Google Scholar : PubMed/NCBI
15	Iglesias MA, Ye JM, Frangioudakis G, et al: AICAR administration causes an apparent enhancement of muscle and liver insulin action in insulin-resistant high-fat-fed rats. Diabetes. 51:2886–2894. 2002. View Article : Google Scholar : PubMed/NCBI
16	Sato T, Man ZW, Toide K and Asahi Y: Plasma membrane content of insulin-regulated glucose transporter in skeletal muscle of the male Otsuka Long-Evans Tokushima Fatty rat, a model of non-insulin-dependent diabetes mellitus. FEBS Lett. 407:329–332. 1997. View Article : Google Scholar
17	Wang ZQ, Zhang XH, Yu Y, et al: Bioactives from bitter melon enhance insulin signaling and modulate acyl carnitine content in skeletal muscle in high-fat diet-fed mice. J Nutr Biochem. 22:1064–1073. 2011. View Article : Google Scholar : PubMed/NCBI
18	Hernández-Alvarez MI, Thabit H, Burns N, et al: Subjects with early-onset type 2 diabetes show defective activation of the skeletal muscle PGC-1{alpha}/Mitofusin-2 regulatory pathway in response to physical activity. Diabetes Care. 33:645–651. 2010.PubMed/NCBI
19	Mingrone G, Manco M, Calvani M, Castagneto M, Naon D and Zorzano A: Could the low level of expression of the gene encoding skeletal muscle mitofusin-2 account for the metabolic inflexibility of obesity? Diabetologia. 48:2108–2114. 2005. View Article : Google Scholar : PubMed/NCBI
20	Chen X and Xu Y: Liver-specific reduction of Mfn2 protein by RNAi results in impaired glycometabolism and lipid homeostasis in BALB/c mice. J Huazhong Univ Sci Technolog Med Sci. 29:689–696. 2009. View Article : Google Scholar : PubMed/NCBI
21	Mingrone G, Rosa G, Di Rocco P, et al: Skeletal muscle triglycerides lowering is associated with net improvement of insulin sensitivity, TNF-alpha reduction and GLUT4 expression enhancement. Int J Obes Relat Metab Disord. 26:1165–1172. 2002. View Article : Google Scholar : PubMed/NCBI
22	Yu H, Guo Y, Mi L, Wang X, Li L and Gao W: Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy. J Cardiovasc Pharmacol Ther. 16:205–211. 2011. View Article : Google Scholar : PubMed/NCBI
23	Guo YH, Chen K, Gao W, et al: Overexpression of Mitofusin 2 inhibited oxidized low-density lipoprotein induced vascular smooth muscle cell proliferation and reduced atherosclerotic lesion formation in rabbit. Biochem Biophys Res Commun. 363:411–417. 2007. View Article : Google Scholar
24	Lugus JJ, Ngoh GA, Bachschmid MM and Walsh K: Mitofusins are required for angiogenic function and modulate different signaling pathways in cultured endothelial cells. J Mol Cell Cardiol. 51:885–893. 2011. View Article : Google Scholar : PubMed/NCBI
25	Wan-Xin T, Tian-Lei C, Ben W, Wei-Hua W and Ping F: Effect of mitofusin 2 overexpression on the proliferation and apoptosis of high-glucose-induced rat glomerular mesangial cells. J Nephrol. 25:1023–1030. 2012. View Article : Google Scholar : PubMed/NCBI